For a medical practitioner
Abnormal uterine bleeding: modern analysis of etiopathogenesis, diagnosis and treatmentSytnіk P.O. 4(144) – VII/VIII 2021 10
Treatment of exacerbation of bronchoobstructive diseases during COVID-19Ostrovsky M.M. 3(143) – V/VI 2021 14
Increasing the risks of the spread of in-hospital infection during the COVID-19 pandemic in UkraineKatrushov O.V. Kaydashev I.P. 3(143) – V/VI 2021 10
Endothelial dysfunction in COVID-19 (literature review)Pak A.I. Shevchuk O.O. Paliy S.M. Selskiy B.P.... 3(143) – V/VI 2021 13
New in treatment of children with autism spectrum disorders (literature review)Bobrova V.I. Bobrova O.V. 3(143) – V/VI 2021 14
The place and role of myofascial dysfunction in the etiopathogenesis of tension headacheDelva M.Yu. Delva I.I. 3(143) – V/VI 2021 14
Risk factors and prevention of thrombosis in patients with COVID-19Khaniukov O.O. Sapozhnychenko L.V. Kalashnikova O.S. Somilo O.V.... 2(142) – III/IV 2021 18
Modern view on pathogenetic mechanisms of long-term consequences forming following mild traumatic brain injuryLekomtseva Ye.V. 2(142) – III/IV 2021 8
Promising opportunities to prevent the appearance and progression of liver fibrosisShvets O.V. 2(142) – III/IV 2021 12
Antibiotic-associated diarrhea: the role of probiotics in the treatment and preventionSkrypnyk І.M. Prykhodko N.P. 2(142) – III/IV 2021 17
Prevention of dysfunctional uterine bleeding during pubertyKostynska N.Ye. Kostynsky G.B. 2(142) – III/IV 2021 12
Late-onset epilepsy: peculiarities of diagnostics and treatmentMaryenko L.B. Maryenko K.M. 1(141) – I/II 2021 14
Treatment of Parkinson’s disease: the potential of extended-release pramipexoleKaraban I.M. 1(141) – I/II 2021 20
Neurometabolic strategy of pharmacotherapy of affective disorders: whom, when and why?Burchinsky S.G. 1(141) – I/II 2021 20
Coronavirus disease 2019 (COVID-19) and pregnancy. Literature reviewSytnіk P.O. Sytnik P.O. 6(1) (140) – XI/XII 2020 22
